paul.nowak wrote: Matt, thanks for the comments. I made an error on the version of Plone. It's 2.5 Plone running on Zope 2.9x.
In regards to the additional products, we have a skin installed and we have a product that we had custom developed for us that connects to a PostgreSQL database. We've looked at slow PostgreSQL queries causing problems and have not been able to find an issue. We've also tested for the case where the PostgreSQL server is down and have not been able to create an issue. We therefor...
LA JOLLA, CA -- (MARKET WIRE) -- 04/25/07 -- Dr. Michael Mahdavi is among the early
adopters of a new wireless technology that detects acidic reflux in the
airway. The Restech Dx-pH Measurement System(TM) received nationwide
acclaim for its clinical significance, delivering clear insight into a
rising incidence of reflux-related disorders.
Laryngopharyngeal reflux disease (LPRD) is known in medical circles as a
"silent disease." It is difficult to detect because conventional pH
measurement systems cannot function properly above the esophagus due to
sensor dry-out. The Restech Dx-pH Probe(TM) incorporates the first and only
pH sensor capable of self-condensing, thus facilitating reliable
measurement and recording of aerosolized reflux in the upper airway.
Like scores of other physicians around the country, Dr. Mahdavi turned to
the Restech Dx-System not only to detect a stealthy and common disease
state, but also to gauge the effectiveness of empirically prescribed Proton
Pump Inhibitor (PPI) therapy (Nexium®, AcipHex®, Prilosec®).
A recent meta-analysis of empiric treatment of LPR with PPI trials,
published by Karkos and Wilson (Laryngoscope), concluded that "the few
randomized, controlled trials have failed to demonstrate superiority of
PPIs over placebo for treatment of suspected LPR." This new evidence is
making some doctors think twice before prescribing PPIs without a positive
pH study.
Dr. Mahdavi asserted, "After performing several studies with the Dx-System,
I will begin to pre-screen patients with the Restech Dx-System as a filter
for patients who may or may not need PPI therapy. We feel this system will
speed up patient diagnoses and cut down on patient costs in the end."
Leo Roucher, CEO of Restech, added, "One of our end-goals is to cut down on
the overall cost of treating patients with reflux. If our system can
indicate whether or not PPI therapy is necessary before a patient is
treated, that would be one great outcome for our product."
Dr. Mahdavi is Medical Director for the San Diego Ear, Head and Neck
Medical Center in La Jolla, California. He is one of a growing number of
the nation's most reputable and published physicians using the Restech
Dx-System.
Restech is a leader in developing world-class medical technologies
assisting physicians in the diagnosis of reflux related health problems.
For more information on the Dx-pH Measurement System, please contact Debra
Krahel or Bryan Buljat at (800) 352-1512 or visit
http://www.restech-corp.com.
Add to DiggBookmark with del.icio.usAdd to Newsvine